Heyoung Ahn, Ed.D. - Publications

Affiliations: 
2006 Teachers College, Columbia University, New York, NY, United States 
Area:
Adult and Continuing Education

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Kim DS, Ahn HS, Kim HJ. Statin use and incidence and mortality of breast and gynecology cancer: A cohort study using the National Health Insurance claims database. International Journal of Cancer. PMID 34751444 DOI: 10.1002/ijc.33869  0.316
2021 Kim H, Kim DW, Kim M, Lee Y, Ahn HK, Cho JH, Kim IH, Lee YG, Shin SH, Park SE, Jung J, Kang EJ, Ahn MJ. Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11). Cancer. PMID 34705268 DOI: 10.1002/cncr.33984  0.336
2021 Park JH, Yeo JH, Kim YS, Park I, Ahn HK, Shin DB, Lee WK, Yang JY, Kim HS, Sym SJ. Predictive Roles of HER2 Gene Amplification and Neutrophil-to-Lymphocyte Ratio on Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab-Based Chemotherapy. American Journal of Clinical Oncology. PMID 33710139 DOI: 10.1097/COC.0000000000000810  0.507
2019 Kim YS, Ji JH, Oh SY, Lee S, Huh SJ, Lee JH, Song KH, Son CH, Roh MS, Lee GW, Lee J, Kim ST, Kim CK, Jang JS, Hwang IG, ... Ahn HK, et al. A Randomized Controlled Trial of Epidermal Growth Factor Ointment for Treating Epidermal Growth Factor Receptor Inhibitor-Induced Skin Toxicities. The Oncologist. PMID 31492766 DOI: 10.1634/theoncologist.2019-0221  0.519
2019 Park JH, Yeo JH, Kim YS, Ahn HK, Sym S, Shin D, Hwang J, Park I, Kim JH. Portal vein stent for symptomatic malignant portal vein stenosis: A single-center experience. Current Problems in Cancer. PMID 31078310 DOI: 10.1016/j.currproblcancer.2019.04.002  0.4
2018 Kim YS, Park DK, Hwang IC, Ahn HY. Daily Weather Conditions and Anticipated Death from Cancer. Iranian Journal of Public Health. 47: 591-596. PMID 29900145  0.499
2017 Kim EY, Kim K, Kim YS, Ahn HK, Jeong YM, Kim JH, Choi WJ. Prevalence of and Factors Associated with Sarcopenia in Korean Cancer Survivors: Based on Data Obtained by the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2011. Nutrition and Cancer. 1-8. PMID 28107038 DOI: 10.1080/01635581.2017.1267776  0.516
2016 Kim EY, Kim N, Kim YS, Seo JY, Park I, Ahn HK, Jeong YM, Kim JH. Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI. Plos One. 11: e0164056. PMID 27706243 DOI: 10.1371/journal.pone.0164056  0.565
2016 Kim YS, Kim EY, Ahn HK, Cho EK, Jeong YM, Kim JH. Prognostic significance of CT-emphysema score in patients with advanced squamous cell lung cancer. Journal of Thoracic Disease. 8: 1966-73. PMID 27621848 DOI: 10.21037/jtd.2016.06.70  0.563
2016 Kim EY, Kim YS, Seo JY, Park I, Ahn HK, Jeong YM, Kim JH, Kim N. The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer. Plos One. 11: e0161125. PMID 27537502 DOI: 10.1371/journal.pone.0161125  0.576
2016 Kim EY, Kim YS, Park I, Ahn HK, Cho EK, Jeong YM, Kim JH. Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 27364150 DOI: 10.1007/s00520-016-3321-0  0.521
2016 Kim HS, Ku JH, Kim SJ, Hong SJ, Hong SH, Kim HS, Kwon TG, Cho JS, Jeon SS, Joo KJ, Ahn HJ, Park HS, Seong DH, Kwon DD, Kim HJ, et al. Prognostic Factors for Recurrence and Progression in Korean Non-Muscle-Invasive Bladder Cancer Patients: A Retrospective, Multi-Institutional Study. Yonsei Medical Journal. 57: 855-864. PMID 27189277 DOI: 10.3349/ymj.2016.57.4.855  0.325
2016 Park I, Choi SJ, Kim YS, Ahn HK, Hong J, Sym SJ, Park J, Cho EK, Lee JH, Shin YJ, Shin DB. Prognostic Factors for Risk Stratification of Patients Recurrent or Metastatic Pancreatic Adenocarcinoma Who were Treated with Gemcitabine-Based Chemotherapy. Cancer Research and Treatment : Official Journal of Korean Cancer Association. PMID 27034148 DOI: 10.4143/crt.2015.250  0.514
Show low-probability matches.